Anti-Cancer Compounds: The Good And The Bad Side
( Vanderbilt University Medical Center 14-Apr-08 )
Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.
Tadpole soon to help in the fight against cancer and lymphedema
( VIB 5-Mar-07 )
Tadpoles enable us to very quickly identify new genes that play a part in the development and functioning of the lymphatic vessel network.